Precision Medicine Requires IT Beyond Traditional EMRs

Insightful and innovative leaders will focus on their precision medicine strategy and ensure clinicians have the tools they need to leverage the important data generated through genetic and genomic testing

Research initiatives measuring projected growth of the global next-generation sequencing (NGS) market vary somewhat, depending on the specific study. Yet, all agree growth is inevitable and accelerating. Early in 2020, for example, Fortune Business Insights valued the NGS market at $6.3 billion in 2018, and anticipates it reaching $31.4 billion by 2026, a compounded annual growth rate (CAGR) of 22.2 percent.

With more patients being tested—and more providers ordering these tests—it’s critical for health system leaders to evaluate the workflows and solutions available to govern ordering practices...